The usefulness of nutrition and prehabilitation therapy during neoadjuvant chemotherapy for resectable pancreatic cancer:A prospective observational study

The usefulness of nutrition and prehabilitation therapy during neoadjuvant chemotherapy for resectable pancreatic cancer:A prospective observational study - The usefulness of nutrition and prehabilitation therapy during neoadjuvant chemotherapy for resectable pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050927

Enrollment

120

Registered

2023-04-25

Start date

2023-04-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

resectable pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with newly diagnosed resectable pancreatic cancer and neoadjuvant chemotherapy 2)Patients with pathologically confirmed diagnosis of pancreatic cancer

Exclusion criteria

Exclusion criteria: 1) Patients with postoperative recurrence of pancreatic cancer 2) Patients who are unable to undergo surgery after neoadjuvant chemotherapy 3) Patients who are judged to be ineligible for this study by the investigator

Design outcomes

Primary

Measure	Time frame
comparing Nutritional index(Body weight,BMI:body mass index,albumin,PNI:prognostic nutritional index,GPS:glasgow prognostic score,modifiedGPS,NLR:Neutrophile lymphocyte ratio,PLR:Platelet lymphocyte ratio) to historical controls	—

Secondary

Measure	Time frame
Postoperative complications and length of hospital stay Adverse events during neoadjuvant chemotherapy Skeletal muscle mass index,grip strength,6 minute walk test Change in quality of life from the start of chemotherapy to before surgery Completion rate of adjuvant chemotherapy(6 months) Overall survival Recurrence free survival	—

Countries

Japan

Contacts

Public ContactOki Kentaro

Kurashiki Central Hospital Department of Gastroenterology and Hepatology

p023eb@gmail.com0864220210

Outcome results